Alterations in two-component regulatory systems of phoPQ and pmrAB are associated with polymyxin B resistance in clinical isolates of Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 12, 2009, Pages 5150-5154

  Barrow, Kaddy ^a   Kwon, Dong H ^a,b  

^a LONG ISLAND UNIVERSITY   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AZLOCILLIN; CARBENICILLIN; CEFTRIAXONE; CIPROFLOXACIN; DNA; GENTAMICIN; NALIDIXIC ACID; NUCLEOTIDE; POLYMYXIN B; PROTEIN; TICARCILLIN; TOBRAMYCIN;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DNA SEQUENCE; GENE MUTATION; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PHOPQ GENE; PMRAB GENE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; POLYMYXIN B; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; TRANSCRIPTION FACTORS;

EID: 71249110157     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00893-09     Document Type: Article

References (27)

1. Arnold, T. M., G. N. Forrest, and K. J. Messmer. 2007. Polymyxin antibiotics for gram-negative infections. Am. J. Health Syst. Pharm. 64:819-826.
2. CLSI. 2007. Performance standards for antimicrobial susceptibility testing: 17th informational supplement M100-S17. Clinical and Laboratory Standards Institute, Wayne, PA.
3. Driscoll, J. A., S. L. Brody, and M. H. Kollef. 2007. The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections. Drugs 67:351-368.
4. Falagas, M. E., and I. A. Bliziotis. 2007. Pandrug-resistant gram-negative bacteria: the dawn of the post-antibiotic era? Int. J. Antimicrob. Agents 29:630-636.
5. Falagas, M. E., P. K. Koletsi, and I. A. Bliziotis. 2006. The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. J. Med. Microbiol. 55:1619-1629.
6. Falagas, M. E., P. I. Rafailidis, D. K. Matthaiou, S. Virtzili, D. Nikita, and A. Michalopoulos. 2008. Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: characteristics and outcome in a series of 28 patients. Int. J. Antimicrob. Agents 32:450-454.
7. Gambello, M. J., and B. H. Iglewski. 1991. Cloning and characterization of the Pseudomonas aeruginosa lasR gene, a transcriptional activator of elastase expression. J. Bacteriol. 173:3000-3009.
8. Gooderham, W. J., S. L. Gellatly, F. Sanschagrin, J. B. McPhee, M. Bains, C. Cosseau, R. C. Levesque, and R. E. Hancock. 2009. The sensor kinase PhoQ mediates virulence in Pseudomonas aeruginosa. Microbiology 155:699-711.
9. Gooderham, W. J., and R. E. Hancock. 2009. Regulation of virulence and antibiotic resistance by two-component regulatory systems in Pseudomonas aeruginosa. FEMS Microbiol. Rev. 33:279-294.
10. Kuo, L. C., C. J. Yu, L. N. Lee, J. L. Wang, H. C. Wang, P. R. Hsueh, and P. C. Yang. 2003. Clinical features of pandrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Taiwan. J. Formos. Med. Assoc. 102:601-606.
11. Landman, D., S. Bratu, M. Alam, and J. Quale. 2005. Citywide emergence of Pseudomonas aeruginosa strains with reduced susceptibility to polymyxin B. J. Antimicrob. Chemother. 55:954-957.
12. Lodise, T. P., C. D. Miller, J. Graves, J. P. Furuno, J. C. McGregor, B. Lomaestro, E. Graffunder, and L. A. McNutt. 2007. Clinical prediction tool to identify patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk for multidrug resistance. Antimicrob. Agents Chemother. 51:417-422.
13. Macfarlane, E. L., A. Kwasnicka, and R. E. Hancock. 2000. Role of Pseudomonas aeruginosa PhoP-phoQ in resistance to antimicrobial cationic peptides and aminoglycosides. Microbiology 146:2543-2554.
14. Macfarlane, E. L., A. Kwasnicka, M. M. Ochs, and R. E. Hancock. 1999. PhoP-PhoQ homologues in Pseudomonas aeruginosa regulate expression of the outer-membrane protein OprH and polymyxin B resistance. Mol. Microbiol. 34:305-316.
15. Mahenthiralingam, E., M. E. Campbell, J. Foster, J. S. Lam, and D. P. Speert. 1996. Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis. J. Clin. Microbiol. 34:1129-1135.
16. 2+-induced gene regulation in Pseudomonas aeruginosa. J. Bacteriol. 188:3995-4006.
17. McPhee, J. B., S. Lewenza, and R. E. Hancock. 2003. Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa. Mol. Microbiol. 50:205-217.
18. McVay, C. S., M. Velasquez, and J. A. Fralick. 2007. Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound model. Antimicrob. Agents Chemother. 51:1934-1938.
19. Mittal, R., R. K. Khandwaha, V. Gupta, P. K. Mittal, and K. Harjai. 2006. Phenotypic characters of urinary isolates of Pseudomonas aeruginosa and their association with mouse renal colonization. Indian J. Med. Res. 123:67-72.
20. Moskowitz, S. M., R. K. Ernst, and S. I. Miller. 2004. PmrAB, a two-component regulatory system of Pseudomonas aeruginosa that modulates resistance to cationic antimicrobial peptides and addition of aminoarabinose to lipid A. J. Bacteriol. 186:575-579.
21. Park, S. M., C. D. Lu, and A. T. Abdelal. 1997. Cloning and characterization of argR, a gene that participates in regulation of arginine biosynthesis and catabolism in Pseudomonas aeruginosa PAO1. J. Bacteriol. 179:5300-5308.
22. Schweizer, H. P. 1991. Escherichia-Pseudomonas shuttle vectors derived from pUC18/19. Gene 97:109-121.
23. Stibitz, S., W. Black, and S. Falkow. 1986. The construction of a cloning vector designed for gene replacement in Bordetella pertussis. Gene 50:133-140.
24. Trieber, C. A., and D. E. Taylor. 2002. Mutations in the 16S rRNA genes of Helicobacter pylori mediate resistance to tetracycline. J. Bacteriol. 184:2131-2140.
25. Wang, C. Y., J. S. Jerng, K. Y. Chen, L. N. Lee, C. J. Yu, P. R. Hsueh, and P. C. Yang. 2006. Pandrug-resistant Pseudomonas aeruginosa among hospitalised patients: clinical features, risk-factors and outcomes. Clin. Microbiol. Infect. 12:63-68.
26. Yeaman, M. R., and N. Y. Yount. 2003. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 55:27-55.
27. Zavascki, A. P., L. Z. Goldani, J. Li, and R. L. Nation. 2007. Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review. J. Antimicrob. Chemother. 60:1206-1215.